Revelation Biosciences Inc (REVB)
$1.92
Insights on Revelation Biosciences Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 72.6% return, outperforming this stock by 166.3%
Performance
- $1.76$1.98$1.92
8.33%
Downside
Day's Volatility :11.29%
Upside
3.23%
- $1.61$35.40$1.92
16.15%
Downside
52 Weeks Volatility :95.45%
Upside
94.58%
Returns
| Period | Revelation Biosciences Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -43.7% | 0.0% |
6 Months | -91.63% | 0.0% |
1 Year | -93.73% | 0.0% |
3 Years | -99.98% | -22.6% |
Highlights
Market Capitalization | 3.1M |
Book Value | $25.13 |
Earnings Per Share (EPS) | -47.25 |
Wall Street Target Price | 18.7 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -61.08% |
Return On Equity TTM | -3.12% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 90.9M |
EBITDA | -8.6M |
Diluted Eps TTM | -47.25 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -7.53 |
EPS Estimate Next Year | -5.23 |
EPS Estimate Current Quarter | -5.38 |
EPS Estimate Next Quarter | -5.18 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 873.96%
Technicals Summary
Sell
Neutral
Buy
Revelation Biosciences Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Revelation Biosciences Inc | -18.3% | -91.63% | -93.73% | -99.98% | -99.98% |
 Moderna, Inc. | 21.03% | 85.08% | 14.68% | -28.27% | 659.22% |
 Regeneron Pharmaceuticals, Inc. | 3.22% | 20.18% | 31.88% | 93.3% | 227.58% |
 Novo Nordisk A/s | 8.85% | 34.38% | 71.83% | 235.07% | 463.44% |
 Vertex Pharmaceuticals Incorporated | 16.81% | 34.1% | 40.6% | 123.97% | 174.53% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Revelation Biosciences Inc | 0.5 | NA | NA | -7.53 | -0.03 | -0.61 | NA | 25.13 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.14 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 28.89 | 28.89 | 1.46 | 44.13 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 46.97 | 46.97 | 2.36 | 3.5 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 29.59 | 29.59 | 0.53 | 17.08 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Revelation Biosciences Inc | Buy | $3.1M | -99.98% | 0.5 | 0.0% |
Moderna, Inc. | Buy | $54.6B | 659.22% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $108.0B | 227.58% | 28.89 | 29.45% |
Novo Nordisk A/s | Buy | $602.6B | 463.44% | 46.97 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $117.5B | 174.53% | 29.59 | 39.46% |
Institutional Holdings
UBS Group AG
0.26%Advisor Group Holdings, Inc.
0.02%
Company Information
we develop immunologic therapeutics and diagnostics designed to make the world a healthier place
Organization | Revelation Biosciences Inc |
Employees | 9 |
CEO | Mr. James M. Rolke |
Industry | Regional Banks |
Discover More
A Spac I Acquisition Corp
$1.92
-0.52%
Keyarch Acquisition Corp
$1.92
-0.52%
Connexa Sports Technologies Inc
$1.92
-0.52%
Us Value Etf
$1.92
-0.52%
First Wave Biopharma Inc
$1.92
-0.52%
Global X Msci Next Emerging
$1.92
-0.52%
Fat Projects Acquisition Corp
$1.92
-0.52%
Goal Acquisitions Corp
$1.92
-0.52%
Capital Link Global Fintech
$1.92
-0.52%